|
|
Volumn 94, Issue , 1998, Pages 231-254
|
|
Endocrine therapy in metastatic breast cancer.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIANDROGEN;
ANTIESTROGEN;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
AROMATASE INHIBITOR;
ENZYME INHIBITOR;
ESTROGEN;
ESTROGEN RECEPTOR;
GESTAGEN;
GONADORELIN;
GROWTH FACTOR RECEPTOR;
GROWTH PROMOTOR;
HORMONE ANTAGONIST;
MIFEPRISTONE;
PROGESTERONE RECEPTOR;
TAMOXIFEN;
TUMOR PROTEIN;
ADULT;
AGED;
BREAST TUMOR;
DRUG EFFECT;
DRUG POTENTIATION;
FEMALE;
HUMAN;
MENOPAUSE;
METASTASIS;
MIDDLE AGED;
MORTALITY;
NEOPLASM;
PALLIATIVE THERAPY;
PATHOLOGY;
PHYSIOLOGY;
REVIEW;
ADULT;
AGED;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
AROMATASE INHIBITORS;
BREAST NEOPLASMS;
ENZYME INHIBITORS;
ESTROGEN ANTAGONISTS;
ESTROGENS;
FEMALE;
GONADOTROPIN-RELEASING HORMONE;
GROWTH SUBSTANCES;
HORMONE ANTAGONISTS;
HUMANS;
MENOPAUSE;
MIDDLE AGED;
MIFEPRISTONE;
NEOPLASM METASTASIS;
NEOPLASM PROTEINS;
NEOPLASMS, HORMONE-DEPENDENT;
PALLIATIVE CARE;
PROGESTINS;
RECEPTORS, ESTROGEN;
RECEPTORS, GROWTH FACTOR;
RECEPTORS, PROGESTERONE;
TAMOXIFEN;
MLCS;
MLOWN;
|
|
EID: 0031638276
PISSN: 09273042
EISSN: None
Source Type: Journal
DOI: 10.1007/978-1-4615-6189-7_13 Document Type: Review |
|
Times cited : (18)
|
|
References (149)
|
